Turning Point Brands, Inc. (TPB) SEC Filings & Earnings Calls

CEO departure creates leadership transition risk, though successor is internal and experienced.

“CEO resignation for personal reasons; immediate appointment of Executive Chairman as CEO.”

EBITDA guidance tightening due to freight cost pressure and delayed onshoring benefits.

“tightening its full-year EBITDA guidance range ... assuming no margin benefit from onshoring manufacturing until 2027 and prolonged, higher freight costs.”

Regulatory risk from FDA

“The U.S. Food and Drug Administration ("FDA") continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing and ultimate implementation of such measures remain unclear.” · word for word

SG&A expense growth

“Selling, general, and administrative expenses $ 76,991 $ 40,296 $ 36,695 91.1%”

Dependence on third-party suppliers

“our dependence on a small number of third-party suppliers and producers” · word for word

Heavy investment phase is compressing profitability: net income -75.2%, adjusted EBITDA -50.0%, adjusted EPS -76.5%.

“Net Income decreased 75.2% to $3.6 million; Adjusted EBITDA decreased 50.0% to $15.2 million; Adjusted Diluted EPS of $0.23 compared to $0.98.”

Zig-Zag segment continues to decline with net sales -24.8%, indicating structural headwinds in traditional smoking accessories.

“Zig-Zag segment Net Sales decreased 24.8%.” · word for word

SG&A expenses surged 91.1% to $76.9M, outpacing revenue growth, raising concerns about cost control and path to profitability.

“consolidated selling, general and administrative (“SG&A”) expenses increased 91.1% from the prior year to $76.9 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.” · word for word

Declining tobacco sales and regulatory pressure

“Declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall; substantial and increasing regulation and changes in U.S. Food and Drug Administration (FDA) enforcement priorities.” · word for word

Dependence on third-party suppliers

“Our dependence on a small number of third-party suppliers and producers; the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost.” · word for word

Intense competition and illicit products

“Intense competition and our ability to compete effectively; competition from illicit sources and the damage caused by illicit products to our brand equity.” · word for word

FDA regulation and marketing denials

“Regulation or marketing denials of our products by the FDA, which has broad regulatory powers; many of our products contain nicotine, which is considered to be a highly addictive substance.” · word for word

Tariff and tax increases

“Imposition of significant tariffs on imports into the U.S.; possible significant increases in federal, state and local municipal tobacco- and nicotine-related taxes.” · word for word

Zig-Zag segment decline may indicate structural headwinds in traditional smoking accessories.

“Zig-Zag segment net sales decreased 22.4% driven by lower U.S. papers and wraps shipments.”

SG&A expenses increased 53.2%, outpacing revenue growth, pressuring margins.

“consolidated SG&A expenses increased 53.2% from the prior year to $55.8 million, inclusive of Modern Oral-related sales and marketing investments and increased outbound freight costs.”

Adjusted EBITDA and net income declined year-over-year despite revenue growth.

“Adjusted EBITDA decreased 6.5% to $25.9 million; Net Income decreased 19.0% to $11.7 million.”

Regulatory risk in tobacco industry

“The Company faces a number of risks, including but not limited to, economic, environmental, social and regulatory risks, and others such as the impact of competition and cybersecurity.” · word for word

Key person dependency on Executive Chairman

“Mr. Glazek was appointed Executive Chairman in January 2023. ... During 2025, Mr. Glazek entered into a letter agreement with the Company, in connection with his continued appointment as Executive Chairman”

Tariff exposure on imported products

“We incurred tariff charges on certain products we import from overseas manufacturers. ... Gross profit as a percentage of net sales decreased to 53.7% ... driven primarily by Zig-Zag cigar wraps margins due to imposed tariffs.” · word for word

Zig-Zag segment revenue decline

“Net sales in the Zig-Zag products segment decreased $13.9 million, or 7.2% ... driven primarily by $15.2 million decline in U.S. papers, wraps, as well as $1.7 million decline in cigars.” · word for word

Regulatory risk (FDA PMTA)

“The FDA has implemented a premarket review process, referred to as the PMTA ... The PMTA process is a very expensive and resource-intensive process.” · word for word

Zig-Zag segment continues to decline; FDA PMTA-related expenses and regulatory compliance costs are increasing.

“Zig-Zag segment Net Sales decreased 12.8% in Q4 2025. $1.1 million of FDA PMTA-related expenses in Q4 2025 vs $0.5 million in prior year.” · word for word

Regulatory risk from FDA PMTA process for Modern Oral products; $0.5M in PMTA expenses.

“$0.5 million of FDA PMTA-related expenses for Modern Oral products” · word for word

Zig-Zag segment decline due to Clipper wind-down; ongoing headwinds in traditional smoking accessories.

“Zig-Zag segment net sales decreased 10.5% from the prior year... Excluding the previously discussed wind-down of our Clipper business, Zig-Zag was up mid-single-digits sequentially.” · word for word

Dilution risk from ATM program; $200M additional capacity authorized.

“the Company plans to amend its ATM prospectus supplement and buyback authorization to provide for $200 million of capacity under each program.” · word for word

Regulatory risk from FDA flavor bans

“The U.S. Food and Drug Administration ("FDA") continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing and ultimate implementation of such measures remain unclear.” · word for word

Supply chain concentration risk

“our dependence on a small number of third-party suppliers and producers” · word for word

Tobacco industry decline

“declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall” · word for word

Product liability litigation

“significant product liability litigation” · word for word

Dilution risk from ATM program; $200M additional capacity could dilute existing shareholders.

“increasing the aggregate dollar amount of Common Stock available to be sold from time to time pursuant to the sales agreement by $200,000,000” · word for word